Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
What
market
4
×
patients
cancer
drug
medicine
therapies
ability
advantages
bar
benefiting
billion
bio
boston
bring
brings
businesses
car
cell
cellular
chain
clinic
clinical
coming
companies
delivery
developing
diagnostics
eisai
expect
expected
fda
fighting
flags
gamble
ge
gene
genetic
glimcher
groundbreaking
headline
Language
unset
Current search:
market
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@techcrunch.com
6 years ago
GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market
